Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-20

Clinical Trial Update: Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for mesenchymal stem cell transplantation in acute-on-chronic liver failure across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Tianjin Weikai Bioeng., Ltd. | Conditions: Liver Failure, Acute on Chronic | Phase 1, Phase 2 | Status: UNKNOWN